Quantcast
Connect with us

EpiPen maker Mylan faces anti-trust investigation following massive price increase

Published

on

The maker of the Epipen, used for the emergency treatment of anaphylactic shock, is facing a federal anti-trust investigation after lawmakers were alerted to a massive price increase last year.

According to the Washington Post, Mylan, the maker of the injectable drug, admitted that the Federal Trade Commission requested information from them months ago “as part of a preliminary investigation.”

ADVERTISEMENT

Mylan has been under scrutiny after raising the price of the EpiPen more than 500 percent in recent years, to over $600 per two-pack.

Adding fuel to the fire was the fact that Mylan’s CEO, Heather Bresch, is the daughter of Democratic West Virginia Sen. Joe Manchin. Bresch helped engineer the bump in prices after taking over as head of the company.

At issue now are accusation that Mylan may have tried to halt competition while reaping huge profits.

Mylan is already under scrutiny by New York Attorney General Eric Schneiderman, who opened an investigation into their business practices last September, accusing the company of inserting “potentially anticompetitive terms” into its sales contracts for Epipen “with numerous local school systems.”

By law, those schools must keep EpiPens on hand for the protection of children.

ADVERTISEMENT

A spokesperson for Mylan dismissed the accusations of illegal actions, calling them “without merit.”

“Any suggestion that Mylan took any inappropriate or unlawful actions to prevent generic competition is without merit,” spokesperson Nina Devlin said in a statement. “”We note that the epinephrine auto-injector market is and always has been competitive, with multiple products competing on the market since we acquired EpiPen Auto-Injector.”

Devlin added, “Further, Teva has had patent licenses to launch their proposed generic alternative to EpiPen Auto-Injector since June 2015, pending FDA approval, years prior to patent expiry.”

ADVERTISEMENT

In October, Mylan agreed to pay a $465 million settlement, without an admission of wrongdoing, with the Justice Department over claims the company over-billed Medicaid by misclassifying the EpiPen in order to take advantage of a federal drug rebate program.


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

‘Comparing yourself to terrorists?’ Internet cracks up at Trump saying dead 9-11 hijackers got more justice than him

Published

on

President Donald Trump quoted Fox News host Mark Levin that left many scratching their heads. Levin, who has a show on Sunday evenings, claimed that the terrorists from Sept. 11 got more due process than the president.

The claim was a curious one because, as many on Twitter noted, it's not often that the president of the United States compares himself to a terrorist. Secondly, the 9-11 hijackers all died in the attack, as they were on the planes that crashed into the buildings and into a Pennsylvania field.

Trump is known to quote Levin frequently, though the citations often make the president look worse.

Continue Reading

Breaking Banner

MLK was ‘gravely disappointed’ with white moderates — whom he believed were responsible for impeding civil rights

Published

on

"We also realize that the problems of racial injustice and economic injustice cannot be solved without a radical redistribution of political and economic power."

—Martin Luther King Jr., 1967

This Martin Luther King Jr. Day comes as moderate Democrats, falling in line behind former vice president Joe Biden, are warning that the party risks re-electing Donald Trump if it nominates too radical a candidate for president — by which they mean someone like Senators Bernie Sanders or Elizabeth Warren.

Continue Reading
 

Breaking Banner

Harvard law professor Laurence Tribe catches Alan Dershowitz in humiliating hypocrisy: ‘He’s not to be trusted’

Published

on

Harvard Constitutional law professor Laurence Tribe called out President Donald Trump's lawyer, Alan Dershowitz, Sunday on Twitter, noting that his opinions seem to evolve depending on who he's defending.

Dershowitz is on a kind of press junket for the president, defending him in various media appearances. The former lawyer to Jeffrey Epstein is handling Trump's defense as it pertains to the abuse of power. Dershowitz thinks that charge has no basis in law. In fact, impeachment trials aren't actually legal proceedings, they're political proceedings, because the Justice Department claimed that Trump can't be indicted under the law while he's president.

Continue Reading
 
 
Help Raw Story Uncover Injustice. Join Raw Story Investigates for $1 and go ad-free.
close-image